Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factors, Cancer Types and Prognostic Significance of Second Primary Cancer Based on the Early-onset and Late-onset Colorectal Cancer

NCT06423924 is registered in ClinicalTrials.gov with LI XIN-XIANG as lead sponsor.

NCT NCT06423924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06423924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factors, Cancer Types and Prognostic Significance of Second Primary Cancer Based on the Early-onset and Late-onset Colorectal Cancer
Lead sponsor
LI XIN-XIANG
Phase
Observational
Overall status
Unknown status
Start date
May 11, 2024
Completion date
June 1, 2024
Enrollment
10,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, second primary cancer